Claritin Logo PNG
The Claritin logo emphasizes the medication’s medical effectiveness. Its simple design is associated with reliability, clarity of action, and consumer trust.
Claritin was introduced in 1980, when Schering-Plough developed loratadine, a new-generation antihistamine without sedative effects. After an extended approval process, the FDA cleared Claritin for the U.S. market in 1993.
The product line expanded to include Claritin-D, adding pseudoephedrine for comprehensive relief of allergy symptoms. A large consumer-focused advertising campaign launched in the mid-1990s significantly increased sales.
By 1999, Claritin led antihistamine sales with $2.7 billion in sales, capturing over 40% of the allergic rhinitis market. Clarinex (desloratadine), a loratadine metabolite, followed in 2001.
After patent expiration in 2002, Claritin became an over-the-counter medication and maintained a strong market share. Schering-Plough merged with Merck & Co. in 2009, and Bayer acquired Claritin in 2014.
Today, Claritin, managed by Bayer, remains a top OTC antihistamine and is listed among the World Health Organization’s essential medicines.
Meaning and History
What is Claritin?
It is a common antihistamine medication containing loratadine that relieves allergy symptoms. It effectively treats runny nose, itching, watery eyes, and sneezing without causing drowsiness. The effect lasts for 24 hours, helping people during pollen season and exposure to seasonal allergens. Available in convenient forms, including syrup and dissolving tablets, these products are sold over the counter.
2003 – today
The Claritin logo, introduced in its current form in 2003, has maintained a consistent graphic design despite changes in brand ownership, from Schering-Plough to Merck & Co. in 2009 and subsequently to Bayer after Merck acquired Merck’s consumer division in 2014. The visual identity has remained unchanged, reinforcing the brand’s recognizability.
The typography is a customized humanist sans serif, similar in style to the well-known Frutiger typeface, with modifications that highlight the brand’s individuality. The word “Claritin” features smooth, slightly right-leaning letters with soft, rounded stroke endings, evoking a sense of lightness and airiness. The dots above the “i” characters are uniquely styled, shifted upward and to the right, forming a visual metaphor for airborne pollen that the product helps eliminate.
The color palette centers on the proprietary “Claritin Blue,” a muted yet vibrant shade. This color symbolically conveys a clear sky, freshness, and unobstructed breathing, underscoring the product’s effectiveness in relieving allergy symptoms without causing drowsiness.
The additional “Non-Drowsy” text at the top of the logo serves as a strategic marketing element, highlighting Claritin’s key competitive advantage, the absence of a sedative effect. At the bottom, the “Allergy Products” tagline highlights the brand’s comprehensive product line, including tablets, syrups, and other formulations.
Claritin’s visual style was initially developed by the company’s in-house branding division during the Merck era, with later adaptation and refinement in partnership with Deutsch Inc., which handled media creative and packaging design until 2005.
The logo’s symbolic meaning ties directly to the product’s purpose: the light, airy letterforms underscore the promise of easier breathing and relief from allergy symptoms. The airborne dot above the “i” reinforces this symbolism, representing the removal of allergens and the relief it brings.
Claritin’s packaging design features imagery of a clear blue sky with white clouds and a lush green field, reflecting a life free from allergic reactions. A distinctive red vertical stripe on the side of the package conveys speed and effectiveness, creating strong contrast and making the product instantly recognizable on the shelf.
